Cite
HARVARD Citation
Bradley, J. et al. (n.d.). Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet oncology. 16 (2), pp. 187-199. [Online].